Provided by Tiger Trade Technology Pte. Ltd.

Repligen

181.13
+0.84000.47%
Post-market: 181.00-0.1300-0.07%19:30 EDT
Volume:1.10M
Turnover:198.19M
Market Cap:10.20B
PE:248.12
High:182.43
Open:179.66
Low:175.75
Close:180.29
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.05
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.83
PE(LYR):210.62

Loading ...

Repligen CEO Olivier Loeillot Disposes of 5,426 Common Shares Worth $976,680

Reuters
·
Aug 22

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Repligen (RGEN)

TIPRANKS
·
Aug 21

Q/C Technologies CFO Todd Fagan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 18

Q/C Technologies Q2 Net Loss Widens to $6.62 Million; Operating Loss Widens to $6.79 Million

Reuters
·
Aug 13

BioLife Solutions Swings to Q2 FY26 GAAP Net Income of $45.1 Million; Revenue Rises 21% to $28.5 Million vs Q2 FY25

Reuters
·
Aug 07

Q/C Technologies Names Yossef Ehrlichman Founding Manager of Photonic Integrated Circuit Development

Reuters
·
Aug 04

BioLife Details Strategic Repligen Merger Communication to Staff

TIPRANKS
·
Aug 04

Repligen Says BioLife Deal Targets Q4 Close Pending Regulatory, Shareholder Approvals

Reuters
·
Aug 04

Repligen is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jul 30

Switzerland's Bachem H1 Sales Rise 4.3% on Growth in Clinical Drug Development

Reuters
·
Jul 30

Beta Bionics Q2 Sales Beat Estimates on Pharmacy Channel Growth

Reuters
·
Jul 30

Analysts’ Top Healthcare Picks: Repligen (RGEN), Allogene Therapeutics (ALLO)

TIPRANKS
·
Jul 30

Repligen's Diversity of Growth Drivers Support Return to Mid-Teens Organic Sales Growth, RBC Says

MT Newswires Live
·
Jul 30

Repligen’s Operational Momentum Offset by Full Valuation; Kyle Mikson CFA Reiterates Hold with Unchanged $145 Price Target

TIPRANKS
·
Jul 29

Repligen Stock (RGEN) Rises After Investors Wowed By ‘Market Leading’ Q2 Figures

TIPRANKS
·
Jul 29

RBC Raises Price Target on Repligen to $185 From $160, Keeps Outperform Rating

MT Newswires Live
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN) and Envista Holdings (NVST)

TIPRANKS
·
Jul 29

UK's Abingdon Health Expects FY26 Revenue up 31%

Reuters
·
Jul 29

Repligen Corp : JP Morgan Raises Target Price to $175 from $165

THOMSON REUTERS
·
Jul 29

Repligen Corp : Leerink Partners Raises Target Price to $220.00 from $200.00

THOMSON REUTERS
·
Jul 29